Center-Authored Papers

Filters: Author is Martin, Peter  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2012
Clayton JM, Adler JL, O'Callaghan A, Martin P, Hynson J, Butow PN, Laidsaar-Powell RC, Arnold RM, Tulsky JA, Back AL.  2012.  Intensive communication skills teaching for specialist training in palliative medicine: development and evaluation of an experiential workshop.. Journal of palliative medicine. 15(5):585-91. Abstract
2014
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM et al..  2014.  A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.. British journal of haematology. 165(3):358-63. Abstract
Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A et al..  2014.  PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.. The New England journal of medicine. Abstract
Center-Authored Paper
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM et al..  2014.  A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.. British journal of haematology. 165(3):358-63. Abstract
Clinical Research Division
Clayton JM, Adler JL, O'Callaghan A, Martin P, Hynson J, Butow PN, Laidsaar-Powell RC, Arnold RM, Tulsky JA, Back AL.  2012.  Intensive communication skills teaching for specialist training in palliative medicine: development and evaluation of an experiential workshop.. Journal of palliative medicine. 15(5):585-91. Abstract
Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A et al..  2014.  PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.. The New England journal of medicine. Abstract
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM et al..  2014.  A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.. British journal of haematology. 165(3):358-63. Abstract
February 2014
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM et al..  2014.  A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.. British journal of haematology. 165(3):358-63. Abstract
Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A et al..  2014.  PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.. The New England journal of medicine. Abstract
June 2012
Clayton JM, Adler JL, O'Callaghan A, Martin P, Hynson J, Butow PN, Laidsaar-Powell RC, Arnold RM, Tulsky JA, Back AL.  2012.  Intensive communication skills teaching for specialist training in palliative medicine: development and evaluation of an experiential workshop.. Journal of palliative medicine. 15(5):585-91. Abstract